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Sttmmal'y 
The tumor necrosis factor cx (TNF-o  0 gene is rapidly transcribed in activated T cells via a calcium- 
dependent pathway that does not require de novo protein synthesis, but is completely blocked 
by the immunosuppressive  drugs cyclosporin A (CsA) and FK506. Here we show that calcineurin 
phosphatase activity is both necessary and sufficient for TNF-oe gene transcription in T cells, 
and identify the factor that binds to the g3 element of the the TNF-o~ gene promoter as the 
target for calcineurin action. The ability of analogues of CsA and FKS06 to block calcineurin 
phosphatase activity correlates completely with their ability to inhibit induction of TNF-ol mRNA, 
induction of a TNF-cx promoter reporter plasmid in transiently transfected T cells, and induction 
of the g3 binding factor in an electrophoretic mobility shift assay. Moreover, a cDNA encoding 
the constitutively active form of calcineurin is sufficient to activate the TNF-o~ promoter and 
the K3 element. TNF-oL gene transcription is also highly inducible, CsA-sensitive,  and protein 
synthesis-independent in B cells stimulated through their surface immunoglobulin receptors. 
Using the panel of CsA and FK506 analogues, we show that calcineurin participates in the induction 
of TNF-ol transcription in activated B cells. These results extend our previous demonstration 
that the K3 binding factor is related to NFATp, the preexisting subunit of nuclear factor of activated 
T cells, and suggest that calcineurin-mediated modification of the g3 binding factor in T cells 
is of key importance in the induction of TNF-o~ transcription. 
S 
timulation of T cells through the T cell receptor results 
in several early metabolic events that culminate in the tran- 
scriptional induction of a variety of cytokine genes (reviewed 
in 1 and 2). Among these, the TNF-cx gene is unusual be- 
cause it possesses the characteristics  of an immediate early 
gene. TNF-cx mRNA is induced to maximal levels within 
15-30 min of exposure to T  cell receptor ligands,  and this 
induction does not require de novo protein synthesis (3). 
Moreover,  induction of TNF-cx mRNA does not require a 
combination of calcium ionophore and phorbol ester as ob- 
served for most other cytokines (4, 5), but can be mediated 
by calcium ionophore alone (3). These results suggest that 
TNF-cz gene induction is mediated by transcription factors 
present in unstimulated T cells, which are posttranscription- 
ally modified and activated via calcium-dependent signaling 
pathways  that do not require protein kinase C. 
The calcium- and calmodulin-dependent phosphatase cal- 
cineurin plays a major role in the process of T cell activation 
(reviewed in 6). Stimulated T cells show increased levels of 
calcineurin phosphatase activity (6), presumably as a result 
of the increase in intracellular free calcium that accompanies 
T  cell activation (reviewed in 1). When bound to specific 
intracellular receptors (immunophilins), cyclosporin A (CsA) 
and FK506 inhibit calcineurin phosphatase activity and block 
the transcription of most (if not all) cytokine genes in acti- 
vated T cells (7, 8), thus underscoring the importance of cal- 
cineurin in the T cell immune response. Analogues of CsA 
and FK506 that inhibit the phosphatase activity of calcineurin 
also inhibit the transcription of the cytokine IL-2 (9,  10); 
likewise,  expression  of a constitutively active form of cal- 
cineurin substitutes for the requirement for calcium in IL-2 
gene transcription, permitting transcription in response to 
phorbol ester alone (11, 12). 
Recent work suggests that calcineurin mediates IL-2 gene 
transcription by directly or indirectly modifying the tran- 
scription factor NFATp, which is essential for induction of 
IL-2 and other cytokine genes (13, 14). NFATp, a 120-kD 
phosphoprotein, is present in cytosolic extracts of unstimu- 
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ligands or with calcium ionophores results in the appearance 
of NFATp in nuclear extracts; this process is mediated by cal- 
cineurin since it is blocked by CsA and FKS06 (15, 16). Within 
the nucleus, NFATp binds as a complex with members of 
the Fos and Jun (AP-1) family of proteins to two sites in the 
IL-2 promoter,  thereby mediating IL-2 gene transcription 
(15-19)  NFATp or a closely related protein also binds to the 
K3 element of the TNF-c~ promoter, the element that mediates 
calcium-dependent, CsA-sensitive induction of the gene in 
T cells (3 and McCaffrey, P.G., A.E. Goldfeld, and A. Rao, 
manuscript submitted for publication). 
The TNF-ot gene is distinguished from other cytokine genes 
expressed in activated T cells in that it is also highly induc- 
ible in immunologically stimulated B cells (20-23). TNF-c~ 
gene transcription in B cells stimulated through their surface 
Ig receptors is similar to that in T cells, in that it is also rap- 
idly inducible and protein synthesis-independent (23).  Fur- 
thermore, as in T  cells,  the rapid induction of the gene in 
B cells can also be blocked by the immunosuppressive drugs 
CsA and FK506 (23),  suggesting that the mechanisms gov- 
erning TNF-ot gene induction may be similar in T and B cells. 
Here, we show that calcineurin is a major mediator of 
TNF-o~ gene transcription in activated T and B cells. These 
results suggest strongly that the immediate early transcrip- 
tion of the TNF-ol gene in antigen stimulated lymphocytes 
is dependent on a single calcineurin-mediated signal trans- 
duction  pathway  that  leads  to  the  posttranslational 
modification of preexisting transcription factors.  This con- 
trasts with the transcription of most other cytokine genes 
in activated T cells, which require activation of multiple sig- 
naling pathways including those dependent on protein ki- 
nase C. Thus, the TNF-o~ promoter represents a simple,  di- 
rect system for the study of transcriptional events initiated 
by calcineurin in lymphocytes. Furthermore, the ability of 
immunosuppressive compounds to block TNF-ol gene tran- 
scription, indicate that the TNF-oc promoter and the K3 ele- 
ment may serve as novel targets in drug screening assays de- 
signed to identify new immunosuppressive agents. 
Materials  and Methods 
Cell Culture, Activation, Transfections, and RNA Analysis.  The 
murine IL-2-dependent T cell done Ar-5 was grown and activated 
with monoclonal antibodies or ionomycin as previously described 
(3). The IgG positive human Burkitt's lymphoma cell line, Akata, 
was grown and stimulated with anti-IgG as previously described 
(23). 10 rain before activation, cells  were treated with CsA (Sandoz 
Pharmaceuticals Corp., E. Hanover, NJ) at concentrations of 10 -6 
M, 5  x  10  -7 M, or 10 -7 M or with 1 nM FK506 (Fujisawa, 
Deerfield, IL) or with 1 #M of MeBm2tt-CsA or with 1 #M of 
MeAla  6 CsA as indicated. 15-O-demethyl-FK520 (referred to as 
FK520Me throughout this paper), was used at the concentrations 
of 1 #M or 1 nM as indicated. Rapamycin was used to pretreat 
cells at the concentrations indicated in the figures. MeBm2tl-CsA, 
MeAlar-CsA, FK520Me, and rapamycin were synthesized as pre- 
viously described (9). Transfections,  activation and CAT assays  were 
performed as described (3). KNA was prepared and RNAse pro- 
tection assays were performed as previously described (3, 23). 
Preparation of Cellular Extracts and Electrophoretic Mobility Shift 
Assays (EMSA).  Ar-5 cells were pretreated with CsA (1 /~M), 
MeBmzt (1 /~M), MeAla (1 /~M), FK506 (1 mN), FK520Me (1 
#M),  or  rapamycin (5  x  10 -7  M)  before  stimulation  with 
ionomycin (1 #M) for 30 rain and nuclear extracts were prepared 
as previously described (3). EMSA using approximately 5/xg of 
nuclear proteins were performed using 32P-labeled K3 or -61n to 
-27n oligonucleotide probes as described (3). 
Plasmids.  The -199 TNF-ce promoter/CAT gene construct and 
the (K3)6-61 TNF-c~ CAT construct have been previously  described 
(24). The ~CAM and SR2ce plasmids have been previously de- 
scribed (11). 
Results and Discussion 
To determine whether calcineurin was an intermediate in 
the signal transduction pathway that results in the induction 
of TNF-o~ gene expression in activated lymphocytes, two ap- 
proaches were employed. The first approach involved the use 
of CsA and FK506 analogues (MeBmztt-CsA, MeAlar-CsA, 
FK520Me, and rapamycin), which when complexed with cy- 
dophilin A (CyPA) and FKBP-12 respectively, show different 
binding affinities for calcineurin and differentially inhibit its 
phosphatase activity (9). The ability of these agents to in- 
hibit cytokine gene transcription is strikingly correlated with 
their ability to inhibit calcineurin activity in vitro (9,  10). 
For example, the MeBm2tl-CsA/CyPA complex is a potent 
inhibitor  of calcineurin phosphatase  activity in  vitro  and 
MeBm2tl-CsA inhibits IL-2 gene transcription when added 
to T cells together with an activating stimulus (9). In con- 
trast, neither the MeAIa6-CsA/CyPA and FK520Me/FKBP- 
12 complexes inhibit calcineurin activity in vitro, and neither 
inhibits IL-2 gene transcription when T  cells are activated 
(9). Another analogue, rapamycin, binds to FKBP-12 but does 
not inhibit calcineurin phosphatase activity (reviewed in 10 
and 13). Rapamycin inhibits an event in a distinct mitogenic 
signaling cascade involving a target other than calcineurin 
and has no effect on the CsA- or FK506-sensitive calcium- 
dependent pathway involved in IL-2 gene induction (25). 
To determine whether induction of TNF-ol mRNA in T 
cells was differentially inhibited by the CsA and FK506 ana- 
logues, the murine T  cell clone Ar-5 was stimulated with 
either anti-CD3 or ionomycin in the presence or absence of 
these compounds and RNA was prepared. As shown in Fig. 
1, 1/~M MeBm2tl-CsA substantially inhibited induction of 
TNF-ol mRNA by anti-CD3 (Fig.  1, lane 6), or ionomycin 
(Fig.  1, lane 15), as did 0.1 or 1/~M CsA (Fig.  1, lanes 3-6, 
and 12-14).  In contrast, an equivalent concentration of the 
inactive CsA analogue MeAIar-CsA did not affect induction 
by anti-CD3 (Fig. 1, lanes 7 and 16). Similarly, although only 
1 nM of FK506 greatly inhibited TNF-c~ mRNA induction 
in response to either anti-CD3 (Fig.  1, lane 8) or ionomycin 
(Fig. 1, lane 17), the inactive FK520Me analogue had no effect 
even at 1,000-fold  higher concentration (Fig.  1, lanes 9, 10, 
18,  and I9).  Likewise, rapamycin did not block induction 
of TNF-oe mRNA levels in response to anti-CD3, anti-TCR- 
c~/fl, or ionomycin (data not shown). These results suggest 
that calcineurin is a critical intermediate in the signal trans- 
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by CsA (3). To test the effect of the CsA and FK506 ana- 
logues on binding of nuclear proteins to the K3 element, nu- 
clear extracts were prepared from At-5 cells that had been 
pretreated with the analogues before stimulation by ionomycin 
and an EMSA was performed using the ~c3 element as a probe. 
Figure  1.  Inhibition  of Anti-CD3 and ionomycin induction  of TNF-ot 
gene expression in murine Ar-5 T cells. Cells were stimulated with anti- 
CD3 (otCD3) or ionomycin  (Iono) for 30 rain, in the presence or absence 
of CsA, MeBm2tl-CsA (MeBm2t), MeAIa6-CsA  (MeAla), FK506, or 15- 
O-demethyl-FK520  (FK520Me)  and RNAse mapping of TNF-ot  and 
"y-actin mRNAs was carried out as described in Materials and Methods. 
duction pathway leading to the activation of the TNF-oL gene 
in T  cells. 
A region of the TNF-c~ promoter containing -199 nucleo- 
tides (nt) relative to the mRNA cap site is sufficient for max- 
imal induction of  a linked chloramphenicol acetyl transferase 
(CAT) gene in stimulated  T cells (3). To test whether the 
elements regulated by calcineurin were present in this region, 
we transfected the -199 TNF-ot CAT plasmid into At-5 cells 
and treated the cells with the various drugs before stimula- 
tion with anti-CD3. CsA, FKS06, and the active CsA ana- 
logue MeBm~t potently inhibited CAT activity induced by 
anti-CD3 (Fig. 2 A, lanes 3-5 and 7), whereas the inactive 
analogues MeAla6-CsA and FK520Me  did not (Fig. 2 A, 
lanes 6 and 8). Similar results were obtained when ionomycin 
was used to induce the cells (data not shown). 
The ~c3 element of the TNF-cr promoter, located between 
-106 to -87 nt relative to the TNF-o~ transcription  start site, 
is  the major mediator of the ionomycin-inducible,  CsA- 
sensitive induction of the gene in T cells (3). To determine 
whether transcription  driven solely by the ~c3 element also 
depended on calcineurin phosphatase activity, a CAT plasmid 
containing six copies of the K3 element linked to the min- 
imal TNF-cr  gene promoter was transfected into Ar-5 cells 
and CAT activity in cells stimulated with ionomycin in the 
prsence or absence of the inhibitors was assessed (Fig. 2 B). 
Again these experiments showed that the active CsA ana- 
logue MeBm2tt-CsA  was  a strong inhibitor  to  inducible 
CAT activity driven by the ~c3 multimer (Fig. 2 B, lane 4), 
whereas the inactive analogues MeAla6-CsA (Fig. 2 B, lane 
5),  and FK520Me  (Fig. 2 B,  lane  7) were not. Moreover, 
rapamycin  did  not  block  induction  of CAT  activity  by 
ionomycin (data not shown). Identical results were obtained 
when the cells were stimulated with anti-CD3  (data  not 
shown). Taken together, these data implicate the Jc3 element 
as a major target of  calcineurin  during the activation of  TNF-a 
gene transcription  in activated T  cells. 
The x3 element forms two DNA-protein complexes in 
EMSA with proteins that are present in cytosolic  extracts from 
unstimulated T  cells or nuclear extracts from stimulated T 
cells (3). The appearance of these inducible complexes is rapid, 
Figure 2.  (A) Inhibition  of otCD3 induction  of the human -199 TNF- 
o~/CAT gene fusion in At-5 T cells. Autoradiogram shows results of CAT 
assays of extracts prepared from At-5 cells transfected with the human 
-199 TNF-ot/CAT reporter gene fusion. (B) Inhibition  of ionomycin  in- 
duction of the TNF-ot promoter element It3 fused to a minimal TNF-ot 
promoter in At-5 T-cells. Autoradiogram shows results of CAT assays of 
extracts prepared from At-5 cells transfected with the K3 multimer con- 
struct  (x3)6-61 TNF-o~CAT. Cells were transfected and mock induced 
(UN) or induced with ctCD3 or ionomycin  (Iono) for 18 h in the presence 
or  absence of CsA,  MeBm2tt-CsA  (MeBm2t),  MeAla6-CsA (Me.Ala), 
FKS06, or 15-O-demethyl-FK520 (FK520Me) as indicated. The results 
are representative of three  independent  experiments. 
765  Goldfeld et al.  Brief Definitive Report of TNF-ot CAT activity by the coexpressed constitutively 
active calcineurin was blocked by the addition of CsA at the 
time of transfection (Fig. 4 A, lane 6), as expected since the 
catalytic activity of the truncated calcineurin A chain is still 
inhibited by CsA/CyP complexes (26). Addition ofionomycin 
at 24 h after transfection resulted in increased expression of 
CAT activity (Fig.  4 A, lane  7), by an average of 30%  in 
four independent experiments (as quantified by Betascope  anal- 
ysis).  This ionomycin-dependent increase in CAT activity 
was blocked by addition of CsA 10 min before addition of 
ionomycin (Fig. 4 A, lane 8), suggesting that the effect of 
ionomycin was to potentiate the activity of endogenous cal- 
cineurin rather than to activate independent noncalcineurin- 
mediated pathways. The residual level of CAT activity seen 
in Fig. 4 A, lane 8 most likely reflects the accumulation of 
CAT protein in the 24 h before the addition of ionomycin 
and CsA. In control experiments, cotransfection of the pSRot 
expression vector caused a slight decrease in the level of in- 
duction of CAT activity (Fig. 4 A, lanes 9-12) when corn- 
Figure 3.  Inhibition  of ionomycin induction  of nuclear K3 binding  com- 
plexes. Gel shift experiments with nuclear extracts from ionomycin stimu- 
lated and unstimulated Ar-5 T cells using chemically synthesized K3 (A) 
or -61n to -27n (B) oligonudeotides as probes. Nuclear extracts were pre- 
pared from At-5 T  cells that had been induced with ionomycin for 30 
min in the presence or absence  of CsA, MeBm2tl-CsA (MeBm2t), MeAh  6- 
CsA (MeAla), FKS06, or 15-O-demethyl-FK520  (FK520Me), or rapamycin 
(Papa) as indicated and described in Materials and Methods. The -61n to 
-27n probe (B) binds to a constitutive factor and serves as an internal  con- 
trol for the experiment displayed in A. 
As shown in Fig.  3,  MeBm2tl-CsA (Fig.  3,  lane 4),  CsA 
(Fig. 3, lane 3), and FKS06 (Fig. 3, lane 6) blocked induc- 
tion of the nuclear ~3 binding factors in ionomycin-stimulated 
Ar-5 cells, whereas MeAla6-CsA (Fig. 3, lane 5), FK520Me 
(Fig. 3, lane 7) or rapamycin (Fig. 3, lane 8) do not. Thus, 
induction of the K3 binding complex, induction of TNF-a 
mRNA levels, and induction of CAT activity driven by the 
-199 TNF-o~ promoter or the ~3 multimer all show the same 
pattern of sensitivity to the CsA and FK506 analogues. These 
data suggest strongly that calcineurin is necessary for the 
modification event that allows activation of the ~3 binding 
factor, which in turn is required for TNF-ot gene transcrip- 
tion in stimulated T  cells. However, they do not rule out 
the involvement of other calcium-mediated pathways. 
To test whether calcineurin-mediated signaling might be 
sufficient for activation of the K3 binding factor and TNF-o~ 
gene expression in T cells, a second approach was employed. 
A plasmid that encodes a COOH-terminally truncated cal- 
cineurin A chain, which possesses constitutive phosphatase 
activity (11), was cotransfected with the -199 TNF-c~ CAT 
construct into Ar-5 cells. Under these conditions, we ob- 
served substantial  induction of CAT activity in the absence 
of any stimulation of the T cells (Fig. 4 A, lane 5). Induction 
Figure 4.  Constitutive  expression of calcineurin activates TNF-tx gene 
expression and the ~3 element in Ar-5 T cells. (A) Autoradiogram shows 
results of CAT assays  of extracts prepared from Ar-5 cells transfected with 
the -199 TNF-otCAT gene fusion alone or cotransfected with a plasmid 
that constitutively expresses the catalytic subunit of calcineurin (6CAM) 
or a control plasmid (pSR2r  as indicated. (B) Autoradiogram shows the 
results of CAT assays  of extracts from cells transfected with (K3)6-61  TNF- 
olCAT alone or cotramfected with 8CAM or pSR2o~ as indicated. Cells 
were transfected and either mock induced, treated with CsA at the time 
of transfection, induced with ionomycin (lono), or treated with CsA 10 
min before induction  with ionomycin  (lono/CsA). The cells were treated 
with ionomycin  for 18 h before harvest. The results are representative of 
three independent  experiments. 
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the -199 TNF-oe CAT plasmid alone (Fig.  4 A, lanes  I-4). 
This effect therefore emphasmes the activation of the TNF-oe 
promoter m cells cotransfected with the consututwely actwe 
calcineurin  (Fig.  4 A,  lanes  5-8). 
To test whether the K3 element was indeed the target  of 
calcineurin we cotransfected the K3 multimer CAT plasmld 
either with the constitutively active calcineunn or the vector 
alone (Fig.  4 B). The results paralleled those obtained using 
the -199 TNF-oe CAT construct; the g3 multimer construct 
was inducible by calcineurin alone (Fig. 5 B, lane 5) and this 
induction  was blocked by CsA  (Fig.  5,  lane 6). 
To determine whether induction of TNF-ce gene expres- 
sion in activated B cells also reqmres calcineurin phosphatase 
actiwty, we stimulated Akata human B cells with anti-IgG 
m the presence of the CsA and FK506 analogues.  In B cells 
as in T  cells,  CsA (Fig,  5,  lane 3),  MeBm2tl-CsA  (Fig.  5, 
lane 4),  and FKS06 (Fig.  5,  lane 6),  all potently inhibited 
TNF-oe  mRNA  induction  whereas  MeAla6-CsA  (Fig.  5, 
lane 5),  FK520Me (Fig.  5,  lane  7)  and rapamycm  (Fig.  5, 
lane 8), did not.  Taken  together,  these results demonstrate 
that calcineurin participates m the lnducuon ofTNF-oe gene 
expression m activated B cells as well as in activated T  cells. 
In conclusion,  the data presented establish a pivotal role 
for calcineunn  m  the reduction  of TNF-oe gene transcrip- 
tion in both T  and B cells sumulated through  their surface 
receptors for antigen.  Recently, we have demonstrated that 
antibodles  to  NFATp  supershift  both  the upper  and lower 
~c3 binding complexes in T cell nuclear extracts and that both 
purified and recombinant NFATp brads specifically to the x3 
Figure 5.  Inhlbmon of  Anu-IgG reduction ofTNF-ot gene expression 
in Akata B cells. Cells were stimulated with anti-IgG for 30 mm, m the 
presence or absence of  CsA or FK506 or the various analogues and RNAse 
maplmng  of  TNF-ot and 3'-actm mRNAs was earned out as described above 
element (McCaffrey, P., A. E. Goldfeld, and A. Rao, manu- 
script submitted for pubhcation).  Taken  together with  the 
data presented here, a plausible hypothesis is that calcineunn- 
mediated dephosphorylation of NFATp or an immunologi- 
cally cross reactwe protein, and its binding to the K3 TNF-ce 
promoter element, is sufficient to induce the immediate-early 
expression of the genem  T  cells.  An interesting  question 
for future invesugation is whether similar to its function m 
T  cells,  calcineurin  activates NFATp  or other proteins in B 
cells, which then bind to the x3 element to medmte TNF-oe 
gene transcription. 
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